Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66,413,214
-
Total 13F shares
-
17,919,011
-
Share change
-
+2,581,005
-
Total reported value
-
$82,069,537
-
Price per share
-
$4.58
-
Number of holders
-
31
-
Value change
-
+$11,725,974
-
Number of buys
-
11
-
Number of sells
-
10
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q2 2024
As of 30 Jun 2024,
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,919,011 shares.
The largest 10 holders included
GENERATION INVESTMENT MANAGEMENT LLP, UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA, AKRE CAPITAL MANAGEMENT LLC, Alta Wealth Advisors LLC, PRINCIPAL FINANCIAL GROUP INC, MILLENNIUM MANAGEMENT LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, Bank Pictet & Cie (Europe) AG, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.